To determine whether inactivation of Trp53R270H expression, and subsequent reactivation of WT p53, sensitized pancreatic cancer cells to MAPK or AKT inhibition, we designed a set of experiments. The gene discussed is AKT1; the disease is pancreatic neoplasm.